Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Statistics

Total Valuation

ARWR has a market cap or net worth of $2.39 billion. The enterprise value is $2.42 billion.

Market Cap	2.39B
Enterprise Value	2.42B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024, after market close.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

ARWR has 124.32 million shares outstanding. The number of shares has increased by 8.53% in one year.

Shares Outstanding	124.32M
Shares Change (YoY)	+8.53%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	3.91%
Owned by Institutions (%)	73.13%
Float	110.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	113.04
Forward PS	16.71
PB Ratio	7.23
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	123.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.65, with a Debt / Equity ratio of 1.34.

Current Ratio	4.65
Quick Ratio	4.49
Debt / Equity	1.34
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.83

Financial Efficiency

Return on equity (ROE) is -151.84% and return on invested capital (ROIC) is -44.97%.

Return on Equity (ROE)	-151.84%
Return on Assets (ROA)	-40.72%
Return on Capital (ROIC)	-44.97%
Revenue Per Employee	$37,425
Profits Per Employee	-$1.03M
Employee Count	525
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-1.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.18% in the last 52 weeks. The beta is 0.96, so ARWR's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-17.18%
50-Day Moving Average	20.76
200-Day Moving Average	25.58
Relative Strength Index (RSI)	41.67
Average Volume (20 Days)	956,674

Short Selling Information

The latest short interest is 9.33 million, so 7.51% of the outstanding shares have been sold short.

Short Interest	9.33M
Short Previous Month	8.92M
Short % of Shares Out	7.51%
Short % of Float	8.45%
Short Ratio (days to cover)	8.12

Income Statement

In the last 12 months, ARWR had revenue of $19.65 million and -$538.64 million in losses. Loss per share was -$4.66.

Revenue	19.65M
Gross Profit	19.65M
Operating Income	-547.21M
Pretax Income	-539.92M
Net Income	-538.64M
EBITDA	-529.78M
EBIT	-547.21M
Loss Per Share	-$4.66

Balance Sheet

The company has $434.47 million in cash and $454.12 million in debt, giving a net cash position of -$19.65 million or -$0.16 per share.

Cash & Cash Equivalents	434.47M
Total Debt	454.12M
Net Cash	-19.65M
Net Cash Per Share	-$0.16
Equity (Book Value)	338.97M
Book Value Per Share	2.66
Working Capital	353.35M

Cash Flow

In the last 12 months, operating cash flow was -$351.56 million and capital expenditures -$181.09 million, giving a free cash flow of -$532.65 million.

Operating Cash Flow	-351.56M
Capital Expenditures	-181.09M
Free Cash Flow	-532.65M
FCF Per Share	-$4.28

Margins

Gross Margin	100.00%
Operating Margin	-2,785.05%
Pretax Margin	-2,792.41%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,707.55%

Dividends & Yields

ARWR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.53%
Shareholder Yield	-8.53%
Earnings Yield	-22.53%
FCF Yield	-22.28%

Analyst Forecast

The average price target for ARWR is $45.33, which is 135.73% higher than the current price. The consensus rating is "Buy".

Price Target	$45.33
Price Target Difference	135.73%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	34.48%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Nov 17, 2011
Split Type	Reverse
Split Ratio	0.1:1

Scores

ARWR has an Altman Z-Score of -0.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.24
Piotroski F-Score	1